Document Detail

Effect of low intravaginal doses of prostaglandin E2 on the closure time of the ductus arteriosus in term newborn infants.
MedLine Citation:
PMID:  8463916     Owner:  NLM     Status:  MEDLINE    
Seventeen term newborn infants (control subjects) and 17 whose mothers had been given intravaginal doses of prostaglandin E2 (PGE2) were examined serially by color Doppler echocardiography to determine whether maternal PGE2 prolonged ductal patency. No clinically relevant differences in closure times were found. Low-dose intravaginal PGE2 therapy was not associated with prolonged ductal patency in term infants.
D A Danford; W F Rayburn; A M Miller; G L Felix; M E Bussey
Related Documents :
19187396 - Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
1731006 - Left ventricular mechanics in the preterm infant and their effect on the measurement of...
7097426 - Radionuclide angiography in the evaluation of ductal shunts in preterm infants.
9568226 - Successful closure of the patent ductus arteriosus by indomethacin in an extremely low ...
1928006 - Posthemorrhagic hydrocephalus. use of an intravenous-type catheter for cerebrospinal fl...
21884226 - United states home births increase 20 percent from 2004 to 2008.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  122     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1993 Apr 
Date Detail:
Created Date:  1993-04-30     Completed Date:  1993-04-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  632-4     Citation Subset:  AIM; IM    
Department of Pediatrics, University of Nebraska College of Medicine, Omaha.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Intravaginal
Dinoprostone* / administration & dosage,  pharmacology
Ductus Arteriosus / drug effects*,  physiology,  ultrasonography
Echocardiography, Doppler
Infant, Newborn
Time Factors
Reg. No./Substance:
0/Oxytocics; 363-24-6/Dinoprostone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of pre...
Next Document:  Nephrocalcinosis in very low birth weight neonates: family history of kidney stones and ethnicity as...